BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SOFIE - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://sofie.com
X-WR-CALDESC:Events for SOFIE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231012
DTEND;VALUE=DATE:20231014
DTSTAMP:20260520T122251
CREATED:20220907T192235Z
LAST-MODIFIED:20230818T015741Z
UID:2668-1697068800-1697241599@sofie.com
SUMMARY:3rd ICPO Forum for Theranostics in Precision Oncology
DESCRIPTION:After the great success of the 2nd ICPO FORUM we are delighted to announce that the 3rd ICPO Forum for Theranostics in Precision Oncology is taking place in Munich Garching from the 12-13 October 2023. \nWe would love to see you onsite on this occasion as we will gather specialists and partners from academia and industry in the field of Precision Oncology\, as well as patient advocates and representatives of non-profit associations coming\, from all over the world. The program under preparation will create a unique opportunity for you to: \n\nGrasp the latest trends on how to expand patient access to Theranostics in Precision Oncology\nExchange with colleagues from across the global ICPO Community\nEnjoy the stimulating program ranging from scientific innovation to patient outcomes\nConnect with ICPO partners during the industry exhibition and social functions
URL:https://sofie.com/event/3rd-icpo-forum-for-theranostics-in-precision-oncology/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2022/09/GarchingMunich.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230909
DTEND;VALUE=DATE:20230914
DTSTAMP:20260520T122251
CREATED:20230907T195831Z
LAST-MODIFIED:20230907T195831Z
UID:3165-1694217600-1694649599@sofie.com
SUMMARY:EANM 23
DESCRIPTION:Visit SOFIE at the upcoming EANM 2023 Congress from September 9 – 13\, 2023 in Vienna\, Austria.
URL:https://sofie.com/event/eanm-23/
ATTACH;FMTTYPE=image/png:https://sofie.com/wp-content/uploads/2023/09/EANM.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230905
DTEND;VALUE=DATE:20230910
DTSTAMP:20260520T122251
CREATED:20230818T014342Z
LAST-MODIFIED:20230818T014757Z
UID:3096-1693872000-1694303999@sofie.com
SUMMARY:2023 Annual World Molecular Imaging Congress
DESCRIPTION:Visit SOFIE at the upcoming 2023 Annual World Molecular Imaging Congress from September 5 – 9\, 2023 in Prague\, Czech Republic.
URL:https://sofie.com/event/2023-annual-world-molecular-imaging-congress/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2023/08/CzechRepublic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230824T153000
DTEND;TZID=America/New_York:20230824T163000
DTSTAMP:20260520T122251
CREATED:20230818T013242Z
LAST-MODIFIED:20230818T014412Z
UID:3090-1692891000-1692894600@sofie.com
SUMMARY:PET/CT Applications for GYN Malignancies
DESCRIPTION:Presenter: Dr. Robert Bridwell\, MD\, MBA\nMedical Advisor at SOFIE \nDr. Robert Bridwell\, medical advisor to SOFIE\, and co-founder of PETLinQ\, is a board-certified physician in both Internal Medicine and Nuclear Medicine. He has extensive knowledge and experience in continuous quality improvement programs for PET and PET/CT imaging\, utilizing physician empowerment training\, protocol development assistance\, and quality assurance guidelines. In the last five years\, Dr. Bridwell has been invited to make numerous presentations\, which have included more than 1200 hours of CME credit delivered to more than 350 institutions\, 100 professional society meetings and more than 150 radiology groups throughout the United States\, Canada and Europe. \nDate: August 24\, 2023\nTime: 3:30pm EDT \nRegister Now\nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers \nIn this webinar\, Dr. Bridwell will help you to: \n\nunderstand the use of FDG PET/CT for cervical cancer\nunderstand the use of FDG PET/CT for endometrial cancer\nunderstand the use of FDG PET/CT for ovarian cancer\ndiscuss the latest updates on FDG PET/CT for GYN malignancies
URL:https://sofie.com/event/pet-ct-applications-for-gyn-malignancies/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2022/10/Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230725
DTEND;VALUE=DATE:20230728
DTSTAMP:20260520T122251
CREATED:20230408T000103Z
LAST-MODIFIED:20230711T142322Z
UID:2986-1690243200-1690502399@sofie.com
SUMMARY:Targeted Radiopharmaceuticals Summit
DESCRIPTION:Sherly Mosessian\, PhD\, SOFIE’S Chief Scientific Officer\, is a featured speaker at the upcoming 2nd Annual Targeted Radiopharmaceuticals Summit US from July 25-27\, 2023 in Boston\, MA. \nMore details on the meeting here.
URL:https://sofie.com/event/targeted-radiopharmaceuticals-summit/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2023/04/Boston.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230614T153000
DTEND;TZID=America/New_York:20230614T163000
DTSTAMP:20260520T122251
CREATED:20230607T000935Z
LAST-MODIFIED:20230607T003559Z
UID:3019-1686756600-1686760200@sofie.com
SUMMARY:Current State of FAP Ligands for Diagnostic Use in Oncology
DESCRIPTION:Presenter: Dr. Sherly Mosessian earned her bachelors degree in Biochemistry\, followed by her Ph.D from UCLA Department of Molecular\, Medical Pharmacology\, with publications in tumor signaling\, molecular imaging targets and clinical trials of Position Emission Tomography (PET) probes. In her role as the Chief Scientific Officer of SOFIE she formulates the strategic plan for scientific objectives of the organization\, including leading the FAPI clinical development program. \nDate: June 14\, 2023\nTime: 3:30pm – 4:30pm EDT \nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers \nIn this session\, Dr. Mosessian will: \n\nexplain the significance of FAP as a target in oncology\nhighlight the progress made to date with FAP targeting ligands for diagnostic use in oncology\ndescribe the current clinical trials and regulatory landscape for FAP targeting ligands\n\nREGISTER NOW\nTHIS ACTIVITY IS APPROVED FOR CREDIT BY THE SNMMI
URL:https://sofie.com/event/current-state-of-fap-ligands-for-diagnostic-use-in-oncology/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2022/10/Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230314
DTEND;VALUE=DATE:20230315
DTSTAMP:20260520T122251
CREATED:20230307T013251Z
LAST-MODIFIED:20230307T013715Z
UID:2954-1678752000-1678838399@sofie.com
SUMMARY:The Future of Radiopharmaceuticals: Targeted Theranostic Therapeutics (digital conference)
DESCRIPTION:Visit SOFIE at The Future of Radiopharmaceuticals: Targeted Theranostic Therapeutics (digital conference) on Tuesday\, March 14. \nDigital Conference\,\n8:00AM EST // 1:00PM GMT // 2:00PM CET \nThe Future of Radiopharmaceuticals: Targeted Theranostic Therapeutics (digital conference) \nSherly Mosessian\, Chief Scientific Officer of SOFIE is presenting: \nFibroblast Activation Protein (FAP) Inhibitors as Biomarkers in Oncology\, Fibrosis\, and Cardiovascular Disease\n\n\nCurrent state of FAP as a target for radioligand and non-radioligand interventions\nClinical development update on fluorine-18 and gallium-68 lead products targeting FAP\nFAPI as a companion diagnostic for patient selection and treatment monitoring in oncology\, fibrosis and cardiovascular disease\n\n\nRadiopharmaceuticals & Imaging\nTuesday\, 14 March 2023 11:05am – 11:35am\nEST (Eastern Standard Time\, GMT-5) \nLearn more
URL:https://sofie.com/event/the-future-of-radiopharmaceuticals-targeted-theranostic-therapeutics/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2022/10/Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230216
DTEND;VALUE=DATE:20230217
DTSTAMP:20260520T122251
CREATED:20230125T212447Z
LAST-MODIFIED:20230125T212928Z
UID:2881-1676505600-1676591999@sofie.com
SUMMARY:Northern California Chapter SNMMI Annual Meeting
DESCRIPTION:Visit SOFIE at the upcoming Northern California Chapter SNMMI Annual Meeting on February 16\, 2023 in Pleasanton\, CA.
URL:https://sofie.com/event/northern-california-chapter-snmmi-annual-meeting/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2023/01/Pleasanton2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230111T153000
DTEND;TZID=America/New_York:20230111T163000
DTSTAMP:20260520T122251
CREATED:20221213T003506Z
LAST-MODIFIED:20230103T172757Z
UID:2854-1673451000-1673454600@sofie.com
SUMMARY:Birth of a Radiopharmaceutical
DESCRIPTION:Presenter: Barbara J Grabher BS\, CNMT\, RT(N)\, NCT\, FSNMMI-TS\nManager\, Application Specialist and Product Technology for Life Molecular Imaging \nBarbara Grabher has been in the field of Nuclear Medicine for over 38 years\, she earned her Associates Degree in Nuclear Medicine from Delaware Technical and Community College in 1983 and earned her bachelor’s degree in Organizational Management from Wilmington University in 2018. She is board-certified by the American Registry of Radiologic Technologists and the Nuclear Medicine Technology Certification Board in both Nuclear Medicine and as a Nuclear Cardiology Technologist. Ms. Grabher received her Nuclear Medicine fellowship status by the SNMMI Technologist section in June 2021 being one of only 109 Nuclear Medicine technologist in the country to receive this recognition. She’s given presentations at the local level as well as nationally\, on topics related to both nuclear cardiology and neurology specializing in DaT imaging and movement disorders as well as amyloid imaging. She’s had 4 manuscripts published in the JNMT Technologist Journal on various topics. Ms. Grabher holds Six Sigma Greenbelt\, LEAN and Blackbelt Certificates specializing in Healthcare. She is a member of the Society of Nuclear Medicine Technologist Section and has affiliations that include the Society of Nuclear Medicine\, and the American Society of Radiologic Technologists. Ms. Grabher is currently a Clinical Applications Specialist for Life Molecular Imaging supporting the amyloid plaque imaging agent Neuraceq. \nDate: January 11\, 2023\nTime: 3:30pm EST \nRegister Now\n  \nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers \nIn this webinar\, Ms. Grabher will help you to: \n\nunderstand the complex process companies go through when getting a radiopharmaceutical FDA approved\nlist the different phases of clinical trials from bench to approval when getting a tracer FDA approved\nknow the different types of FDA Applications and Approvals there are\nrealize the amount of time\, money and resources companies use to hopefully get their tracer approved\nunderstand the importance of clinical trials and the need for diverse patient population participation
URL:https://sofie.com/event/birth-of-a-radiopharmaceutical/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2022/10/Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221027T153000
DTEND;TZID=America/New_York:20221027T163000
DTSTAMP:20260520T122251
CREATED:20221026T185426Z
LAST-MODIFIED:20221026T185640Z
UID:2813-1666884600-1666888200@sofie.com
SUMMARY:Breast Cancer PET/CT Applications Webinar
DESCRIPTION:Presenter: Dr. Robert Bridwell\, MD\, MBA Medical Advisor at SOFIE Dr. Robert Bridwell\, medical advisor to SOFIE\, and co-founder of PETLinQ\, is a board-certified physician in both Internal Medicine and Nuclear Medicine. He has extensive knowledge and experience in continuous quality improvement programs for PET and PET/CT imaging\, utilizing physician empowerment training\, protocol development assistance\, and quality assurance guidelines. In the last five years\, Dr. Bridwell has been invited to make numerous presentations\, which have included more than 1200 hours of CME credit delivered to more than 350 institutions\, 100 professional society meetings and more than 150 radiology groups throughout the United States\, Canada and Europe. \nDate: October 27\, 2022\nTime: 3:30pm – 4:30pm EDT \nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers \nIn this session\, Dr. Bridwell will: \n\nidentify the role of FDG for staging\, restaging and response assessment\nexplain the role of FES for staging and restaging\nhelp you to understand the synergy of FES and FGD as a predictive diagnostic tool\n\nREGISTER NOW\nTHIS ACTIVITY IS APPROVED FOR CREDIT BY THE ASRT\nTo receive CE credit you must register individually\, attend the entire session and complete a post-webinar survey. Instructions regarding receiving CEH (1.0) will be provided at the conclusion of the session. Approved by ASRT Cat A 1.0 VAD00320015
URL:https://sofie.com/event/breast-cancer-pet-ct-applications-webinar/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2022/10/Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220928
DTEND;VALUE=DATE:20221002
DTSTAMP:20260520T122251
CREATED:20220907T185644Z
LAST-MODIFIED:20220916T220618Z
UID:2650-1664323200-1664668799@sofie.com
SUMMARY:World Molecular Imaging Congress
DESCRIPTION:Visit SOFIE at Booth #203 at the upcoming meeting from September 28 – October 1\, 2022 in Miami\, FL. We will also be sponsoring Educational Session 3: Molecular Imaging – Nuclear \n\n\n\n Wednesday\, September 28\, 2022\n 1:30 PM – 3:00 PM\n 242/243\n Education\n\n\n\n\n\nLearning Objectives\n\nRecognize recently developed hybrid imaging methods currently being used in the field.\nAnalyze the various modalities of MI\, such as optical ultrasound\, magnetic resonance imaging (MRI)\, and nuclear medicine\, and compare and contrast the advantages and limits of each.\nRecognize the common concepts that underlie molecular imaging probes for each of the various imaging modalities\, as well as the possibility of multi-modality probes.\nIdentify Molecular Imaging applications and correlate them with the methodologies and probes that have been employed in preclinical and clinical scenarios.\nRecognize the possibilities\, benefits\, and shortcomings of specialized molecular imaging for preclinical\, clinical\, and translational research.\n\nLearn more
URL:https://sofie.com/event/world-molecular-imaging-congress/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2022/09/Miami.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220825
DTEND;VALUE=DATE:20220826
DTSTAMP:20260520T122251
CREATED:20220815T215614Z
LAST-MODIFIED:20220815T215739Z
UID:2632-1661385600-1661471999@sofie.com
SUMMARY:PET Radiation Safety: The New Radiopharms on the Block
DESCRIPTION:Presenter: Kimon Jackson\, MSMP\, MSA\, CNMT\nClinical Account Executive for SOFIE \nA Nuclear Medicine Technologist with 20+ years of imaging experience. Kimon worked as a Nuclear Medicine/PET Supervisor for 12 years while serving as the Nuclear Medicine/PET health system resource. She went back to school earning a Master of Science in Healthcare Administration and Master of Science in Medical Physics. She has also worked as a health system Medical Physicist and Radiation Safety Officer for four years and taught Radiation Safety as adjunct faculty at the ODU Nuclear Medicine program for seven years. Kimon\, provided Radiation Safety in-services to various students\, technologists\, physicians\, and support staff. She also provided a credited Radiation Safety talk to the Virginia Association of Vascular and Interventional Radiographers (AVIR) chapter. Kimon currently is the Mid Atlantic CAE at SOFIE.  \nDate: August 25\, 2022\nTime: 3:30pm EST \nRegister Now\nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers \nIn this webinar\, Ms. Jackson will: \n\nIdentify the “new” PET radiopharmaceuticals\nProvide an overview of the physics of the “new” isotopes\nReview of partial volume effect\nDiscuss radiation safety concepts for the PET environment
URL:https://sofie.com/event/pet-radiation-safety-the-new-radiopharms-on-the-block/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/09/webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220611
DTEND;VALUE=DATE:20220615
DTSTAMP:20260520T122251
CREATED:20220515T025622Z
LAST-MODIFIED:20220526T152221Z
UID:2292-1654905600-1655251199@sofie.com
SUMMARY:SNMMI Annual Meeting 2022
DESCRIPTION:The SNMMI 2022 Annual Meeting is recognized as the premier educational\, scientific\, research\, and networking event in nuclear medicine and molecular imaging. The four day event\, taking place each June\, provides physicians\, technologists\, pharmacists\, laboratory professionals\, and scientists with an in-depth view of the latest research and development in the field as well as providing insights into practical applications for the clinic. \nVisit SOFIE at the upcoming meeting from June 11 – 14\, 2022 in Vancouver\, Canada at Booth #319. \nFAP Satellite Symposium at SNMMI – Sunday\, June 12\, 2022 from 6:30–8:30 pm PDTLearn more \nContact us to learn more about the FAP User Meeting.
URL:https://sofie.com/event/snmmi-annual-meeting-2022/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2022/05/Vancouver.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220608T153000
DTEND;TZID=America/New_York:20220608T163000
DTSTAMP:20260520T122251
CREATED:20220601T234639Z
LAST-MODIFIED:20220601T235001Z
UID:2309-1654702200-1654705800@sofie.com
SUMMARY:Fibroblast Activation Protein (FAP) - A promising target for radiopharmaceuticals
DESCRIPTION:Presenter: Sherly Mosessian\, Ph.D\nSOFIE Chief Scientific Officer \nDr. Mosessian earned her bachelors degree in Biochemistry\, followed by her Ph.D from UCLA Department of Molecular\, Medical Pharmacology\, with publications in tumor signaling\, molecular imaging targets and clinical trials of Position Emission Tomography (PET) probes. In her role as the Chief Scientific Officer of SOFIE she formulates the strategic plan for scientific objectives of the organization\, including leading the FAPI clinical development program. \nDate: June 8\, 2022\nTime: 3:30pm EDT \nRegister Now\nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers \nIn this webinar\, Dr. Mosessian will: \n\nExplain what is FAP and what role it plays in oncology\nIdentify key radiopharmaceuticals involved in FAP targeting\nDescribe the current state of clincal development for FAP Inhibitors (FAPI)
URL:https://sofie.com/event/fibroblast-activation-protein-fap-a-promising-target-for-radiopharmaceuticals/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/09/webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220526T153000
DTEND;TZID=America/New_York:20220526T163000
DTSTAMP:20260520T122251
CREATED:20220515T024729Z
LAST-MODIFIED:20220515T025109Z
UID:2285-1653579000-1653582600@sofie.com
SUMMARY:Seeing the Difference: Advances in the Imaging of Neuroendocrine Tumors
DESCRIPTION:Presenter: Jesse R. Johnson\, BS\, CNMT\nSenior Area Business Manager for Curium \nJess is currently a Senior Area Business Manager with Curium and support their traditional products line such as Mo-99 generators\, Thallium\, xenon etc.\, in addition to Cu-64 DOTOTATE\, Detectnet and most recently I-123 Ioflupane injection. He has had multiple responsibilities and sales positions with Curium over the past 15 years dating back to Tyco Healthcare Mallinckrodt. Prior to this he worked for Dupont/BMS Medical Imaging supporting Cardiolite from the Medical Affairs side of the business. Jesse has also worked 15 years clinically at the Marshfield Clinic in Marshfield\, WI. \nDate: May 26\, 2022\nTime: 3:30pm EDT \nRegister Now\nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers \nIn this webinar\, Jesse will: \n\nReview the structure\, function\, and distribution of neuroendocrine tumors (NETs)\nDescribe the key attributes of NETs that are necessary to understand the advantages and disadvantages of current imaging techniques and technologies\nIdentify currently used imaging technologies for NETs and the benefits and limitations of each
URL:https://sofie.com/event/seeing-the-difference-advances-in-the-imaging-of-neuroendocrine-tumors/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/09/webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220428T153000
DTEND;TZID=America/New_York:20220428T163000
DTSTAMP:20260520T122251
CREATED:20220416T231255Z
LAST-MODIFIED:20220515T025319Z
UID:2107-1651159800-1651163400@sofie.com
SUMMARY:Advantages of Cardiac PET MPI
DESCRIPTION:Presenter: April Mann\, MBA\, CNMT\, NCT\, RT(N)\nVP\, Clinical Development for IONETIX \nMs. Mann is the VP\, Clinical Development for Ionetix. Before entering the industry sector\, she was employed by the Hartford Healthcare System since 1992 and held various roles within the organization and Heart & Vascular Institute. She has been a nuclear medicine technologist since 1989 and has a BA in Healthcare Management and a Masters’\, Business Administration. Ms. Mann has been active within the nuclear medicine/nuclear cardiology community most notably serving as the President\, Society of Nuclear Medicine and Molecular Imaging-Technologist Section She has over 27 publications and has given over 200 presentations on various topics in nuclear medicine\, cardiology and quality and outcomes.  She is well respected in the Imaging community and has several years of leadership\, operations\, and business experience in healthcare. \nDate: April 28\, 2022\nTime: 3:30pm EDT \nRegister Now\nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers \nIn this webinar\, Ms. Mann will: \n\nDiscuss the clinical advantages of Cardiac PET MPI\nDiscuss the considerations for acquisition including protocol and radiopharmaceutical selections\nDiscuss advantages and considerations of performing myocardial blood flow\nDiscuss applications for infection and inflammation imaging
URL:https://sofie.com/event/advantages-of-cardiac-pet-mpi/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/09/webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220331T153000
DTEND;TZID=America/New_York:20220331T163000
DTSTAMP:20260520T122251
CREATED:20220309T224509Z
LAST-MODIFIED:20220309T224834Z
UID:2100-1648740600-1648744200@sofie.com
SUMMARY:Neuroendocrine Tumor Imaging
DESCRIPTION:Presenter: Dr. Robert Bridwell\, MD\, MBA\nMedical Advisor at SOFIE \nDr. Robert Bridwell\, medical advisor to SOFIE\, and co-founder of PETLinQ\, is a board-certified physician in both Internal Medicine and Nuclear Medicine. He has extensive knowledge and experience in continuous quality improvement programs for PET and PET/CT imaging\, utilizing physician empowerment training\, protocol development assistance\, and quality assurance guidelines. In the last five years\, Dr. Bridwell has been invited to make numerous presentations\, which have included more than 1200 hours of CME credit delivered to more than 350 institutions\, 100 professional society meetings and more than 150 radiology groups throughout the United States\, Canada and Europe. \nDate: March 31\, 2022\nTime: 3:30pm EDT \nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers  \nIn this webinar\, Dr. Bridwell will: \n\nhelp you to understand the application of Dotatate imaging for the management of neuroendocrine tumors\nreview the NETPET scoring system and how it may be applied to therapy selection\nshow contrast in the use of Ga-68 labeled and Cu-64 labeled Dotatate imaging\n\nRegister Now
URL:https://sofie.com/event/neuroendocrine-tumor-imaging/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/09/webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220126T153000
DTEND;TZID=America/New_York:20220126T163000
DTSTAMP:20260520T122251
CREATED:20220103T235930Z
LAST-MODIFIED:20220104T002005Z
UID:2063-1643211000-1643214600@sofie.com
SUMMARY:Recognizing Signs and Artifacts in Neuraceq® (F18 florbetaben) PET Scans…How the NM/PET Technologist Ensures Excellent Image Quality
DESCRIPTION:Presenter: Barbara J Grabher BS\, CNMT\, RT(N)\, NCT\, FSNMMI-TS\nClinical Applications Specialist for Life Molecular Imaging \nBarbara Grabher has been in the field of Nuclear Medicine for over 38 years\, she earned her Associates Degree in Nuclear Medicine from Delaware Technical and Community College in 1983 and earned her bachelor’s degree in Organizational Management from Wilmington University in 2018. She is board-certified by the American Registry of Radiologic Technologists and the Nuclear Medicine Technology Certification Board in both Nuclear Medicine and as a Nuclear Cardiology Technologist. Ms. Grabher received her Nuclear Medicine fellowship status by the SNMMI Technologist section in June 2021 being one of only 109 Nuclear Medicine technologist in the country to receive this recognition. She’s given presentations at the local level as well as nationally\, on topics related to both nuclear cardiology and neurology specializing in DaT imaging and movement disorders as well as amyloid imaging. She’s had 4 manuscripts published in the JNMT Technologist Journal on various topics. Ms. Grabher holds Six Sigma Greenbelt\, LEAN and Blackbelt Certificates specializing in Healthcare. She is a member of the Society of Nuclear Medicine Technologist Section and has affiliations that include the Society of Nuclear Medicine\, and the American Society of Radiologic Technologists. Ms. Grabher is currently a Clinical Applications Specialist for Life Molecular Imaging supporting the amyloid plaque imaging agent Neuraceq.\n  \nDate: January 26\, 2022\nTime: 3:30pm EST \nWho should attend?\nPET Interpreters\, Technologists\, Referring Physicians \nIn this webinar\, Ms. Grabher will help you to: \n\nunderstand the importance of β-amyloid imaging and how scan results can change patient management decisions\nrecognize and understand how different signs and artifacts can affect image quality and potential patient outcomes if images are not interpreted correctly\n\nevaluate and recognize Neuraceq® imaging pitfalls and artifacts as well as different distribution patters of Neuraceq®\n\nRegister Now
URL:https://sofie.com/event/recognizing-signs-and-artifacts-in-neuraceq-f18-florbetaben-pet-scanshow-the-nm-pet-technologist-ensures-excellent-image-quality/
ATTACH;FMTTYPE=image/png:https://sofie.com/wp-content/uploads/2021/06/Doc2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211027T153000
DTEND;TZID=America/New_York:20211027T163000
DTSTAMP:20260520T122251
CREATED:20211019T215654Z
LAST-MODIFIED:20211019T220209Z
UID:2020-1635348600-1635352200@sofie.com
SUMMARY:Initiatives in Radiation Safety
DESCRIPTION:Presenter: James G. Fongheiser\, BS\,MS – Independent Consultant – Health Physics\, Radiation Protection and Licensing \nJames Fongheiser\, BS\, MS\, is an independent consultant in health physics\, providing assistance and services in radiation protection and licensing.  \nDate: October 27\, 2021\nTime: 3:30pm EDT \nWho should attend?\nPET Interpreters\, Technologists\, Referring Physicians \nUnderstand the relevant\, key aspects of occupational Exposure Reduction\, including: \n\nideal facilities and engineering controls\ncultural obstacles\npresent day status\n\nUnderstand the relevant\, key aspects of compliance issues and their relevance to US\, by reviewing: \n\nNRC Information Notices\, and \nState Inspection material\n\nUnderstand the relevant\, key aspects of DOT Compliance for Hospitals and outpatient facilities for: \n\nReceipt of radiopharmaceuticals\nReceipt of sealed sources\nReturn or disposal of radioactive material\n\nRegister Now
URL:https://sofie.com/event/initiatives-in-radiation-safety/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/10/RadiationSafety.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210930
DTEND;VALUE=DATE:20211001
DTSTAMP:20260520T122251
CREATED:20210916T220623Z
LAST-MODIFIED:20210916T223251Z
UID:1979-1632960000-1633046399@sofie.com
SUMMARY:Nuclear Medicine Accreditation
DESCRIPTION:Presenter: Carl Grieco\, CNMT\, BS\, Nuclear Medicine/PET Accreditation Consultant \nCarl is a certified nuclear medicine technologist and a qualified radiation safety officer with extensive experience in nuclear medicine accreditation. Carl understands the time demands on the nuclear medicine staff and the effort it takes to obtain and maintain accreditation. Carl actually worked as a site visitor for IAC-Nuclear (ICANL) and the American College of Radiology (ACR) for many years before he began providing accreditation services as a consultant. \nObjectives: \n\nLearn about the different commissions that are approved by CMS.\nDecide which is the best commission for your facility.\nHow accreditation can be used in MIPS\n\nDate: September 30\, 2021 \nTime: 3:30 pm EDT \n***(Approved for 1.0 CE credit from SNMMI CEC10384) \nRegister Now
URL:https://sofie.com/event/nuclear-medicine-accreditation/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/09/webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210715
DTEND;VALUE=DATE:20210721
DTSTAMP:20260520T122251
CREATED:20210626T185833Z
LAST-MODIFIED:20210626T190453Z
UID:1935-1626307200-1626825599@sofie.com
SUMMARY:How to Technically Maximize the Quality of the Information From the Study (CEC10184)
DESCRIPTION:How to Technically Maximize the Quality of the Information From the Study (CEC10184)\nPresenter: Dr. Robert Bridwell\, Board Certified in Nuclear Medicine and Internal Medicine and is currently Medical Advisor for SOFIE and Phyllis Hoelsworth\, Director of Product Launch for SOFIE \nIn this session\, Dr. Bridwell will describe the biodistribution of DCFPyl imaging (F-18 PSMA) to help you to understand the technical maneuvers that can be done to improve the sensitivity to detect pelvic disease and distant metastatic disease. He will also describe the most important clinical characteristics that may impact the sensitivity of the study to include medications\, uptake time and type of patient being imaged. Finally\, he will outline the important questions to ask the patient prior to the scanning process. \nJuly 15\n3:30pm EDT / 12:30pm PDT \nJuly 20\n7:00pm EDT / 4:00 pm PDT \nREGISTER NOW
URL:https://sofie.com/event/how-to-technically-maximize-the-quality-of-the-information-from-the-study-cec10184/
ATTACH;FMTTYPE=image/png:https://sofie.com/wp-content/uploads/2021/06/Doc2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210611
DTEND;VALUE=DATE:20210616
DTSTAMP:20260520T122251
CREATED:20210512T041705Z
LAST-MODIFIED:20210517T194637Z
UID:1696-1623369600-1623801599@sofie.com
SUMMARY:SNMMI 2021 Virtual Annual Meeting
DESCRIPTION:The SNMMI 2021 Annual Meeting is recognized as the premier educational\, scientific\, research\, and networking event in nuclear medicine and molecular imaging. The four day event\, taking place each June\, provides physicians\, technologists\, pharmacists\, laboratory professionals\, and scientists with an in-depth view of the latest research and development in the field as well as providing insights into practical applications for the clinic.
URL:https://sofie.com/event/snmmi-2021-virtual-annual-meeting/
ATTACH;FMTTYPE=image/png:https://sofie.com/wp-content/uploads/2021/05/AM2021_We_are_Exhibiting.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210604T153000
DTEND;TZID=America/New_York:20210604T163000
DTSTAMP:20260520T122251
CREATED:20210512T041053Z
LAST-MODIFIED:20210519T001032Z
UID:1694-1622820600-1622824200@sofie.com
SUMMARY:Bringing PSMA PET/CT Imaging to Your Patients
DESCRIPTION:Presenter: Dr. Robert Bridwell\, Board Certified in Nuclear Medicine and Internal Medicine and is currently Medical Advisor for SOFIE and Phyllis Hoelsworth\, Director of Product Launch for SOFIE \nDr. Bridwell will review the patient profile selection for PSMA imaging and how PSMA imaging will benefit patients as well as where theranostics fits in the prostate cancer space. Phyllis Hoelsworth will then review marketing strategies and best practices for building a successful PSMA program. \nJune 4\n7:00pm EDT / 4:00 pm PDT \nREGISTER NOW
URL:https://sofie.com/event/bringing-psma-pet-ct-imaging-to-your-patients/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/05/Man3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210602T153000
DTEND;TZID=America/New_York:20210602T163000
DTSTAMP:20260520T122251
CREATED:20210425T181707Z
LAST-MODIFIED:20210512T040842Z
UID:1148-1622647800-1622651400@sofie.com
SUMMARY:Bringing PSMA PET/CT Imaging to Your Patients
DESCRIPTION:Bringing PSMA PET/CT Imaging to Your Patients\nPresenter: Dr. Robert Bridwell\, Board Certified in Nuclear Medicine and Internal Medicine and is currently Medical Advisor for SOFIE and Phyllis Hoelsworth\, Director of Product Launch for SOFIE \nDr. Bridwell will review the patient profile selection for PSMA imaging and how PSMA imaging will benefit patients as well as where theranostics fits in the prostate cancer space. Phyllis Hoelsworth will then review marketing strategies and best practices for building a successful PSMA program. \nJune 2\n3:30pm EDT / 12:30pm PDT \nJune 4\n7:00pm EDT / 4:00 pm PDT \nREGISTER NOW
URL:https://sofie.com/event/prostate-cancer-webinar-series/
ATTACH;FMTTYPE=image/png:https://sofie.com/wp-content/uploads/2021/04/Man2.png
END:VEVENT
END:VCALENDAR